Federal Register / Vol. 66, No. 119 / Wednesday, June 20, 2001 / Notices 33107

the Final Reports of the White House

Commission on Complementary and

Alternative Medicine Policy. Major

issues before the Commission include

the following: Coordination of CAM

Research; Access, Delivery, and

Reimbursement of CAM Services and

Products; Training, Education,

Credentialing, and Licensing of CAM

Practitioners; Development and

Dissemination of CAM Information for

Health Care Providers and the Public;

and CAM in Wellness, Self-Care, and

Disease Prevention. Comments received

at the meeting may be used by the

Commission to prepare the Report to the

President as required by the Executive

Order.

Some Commission members may

participate by telephone conference.

Opportunities for oral statements by the

public will be provided on July 3, from

3 p.m.–4 p.m. (Time approximate)

Name of Committee: The White House

Commission on Complementary and

Alternative Medicine Policy.

Date: July 2–3, 2001.

Time: July 2—10 a.m.–6 p.m.; July 3—8

a.m.–4 p.m.

Place: Jurys Washington Hotel, Westbury

Conference Room, 1500 New Hampshire

Ave., NW., Washington, DC 20036, Phone

Number: 202–483–6000.

Contact Persons: Michele M. Chang, CMT,

MPH, Executive Secretary, or Stephen C.

Groft, Pharm.D., Executive Director, 6707

Democracy Boulevard, Room 880, MSC–

5467, Bethesda, MD 20892–5467, Phone:

(301) 435–7592, Fax: (301)480–1691, E-mail:

WHCCAMP@mail.nih.gov.

Because of the need to obtain the views of

the public on these issues as soon as possible

and because of the early deadline for the

report required of the Commission, this

notice is being provided at the earliest

possible time.

Supplementary Information: The President

established the White House Commission on

Complementary and Alternative Medicine

Policy on March 7, 2000 by Executive Order

13147. The mission of the White House

Commission on Complementary and

Alternative Medicine Policy is to provide a

report, through the Secretary of the

Department of Health and Human Services,

on legislative and administrative

recommendations for assuring that public

policy maximizes the benefits of

complementary and alternative medicine to

Americans.

Public Participation

The meeting is open to the public with

attendance limited by the availability of

space on a first come, first served basis.

Members of the public who wish to present

oral comments may register by faxing a

request to register at 301–480–1691 or by

accessing the website of the Commission at

http://wwccamp.hhs.gov no later than June

25, 2001.

Oral comments will be limited to five

minutes, three minutes to make a statement

and two minutes to respond to questions

from Commission members. Due to time

constraints, only one representative from

each organization will be allotted time for

oral testimony. The number of speakers and

the time allotted may also be limited by the

number of registrants. Priority may be given

to participants who have not yet addressed

the Commission at previous meetings. All

requests to register should include the name,

address, telephone number, and business or

professional affiliation of the interested

party, and should indicate the area of interest

or question to be addressed.

Any person attending the meeting who has

not registered to speak in advance of the

meeting will be allowed to make a brief oral

statement during the time set aside for public

comment if time permits, and at the

Chairperson’s discretion. Individuals unable

to attend the meeting, or any interested

parties, may send written comments by mail,

fax, or electronically to the staff office of the

Commission for inclusion in the public

record.

When mailing or faxing written comments,

please provide, if possible, an electronic

version or on a diskette. Persons needing

special assistance, such as sign language

interpretation or other special

accommodations, should contact the

Commission staff at the address or telephone

number listed above no later than June 25,

2001.

Dated: June 14, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–15467 Filed 6–19–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Human Genome Research

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Human

Genome Research Institute Initial Review

Group, Ethical, Legal, Social Implications

Review Committee.

Date: July 12–13, 2001.

Time: 8:00 am to 6:00 pm.

Agenda: To review and evaluate grant

applications.

Place: The Hyatt Regency Hotel, 100

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Rudy O. Pozzatti, PhD,

Scientific Review Administrator, Office of

Scientific Review, National Human Genome

Research Institute, National Institutes of

Health, Bethesda, MD 20892, 301 402–0838.

(Catalogue of Federal Domestic Assistance

Program Nos. 83.172, Human Genome

Research, National Institutes of Health, HHS).

Dated: June 14, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–15463 Filed 6–19–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Environmental

Health Sciences; Notice of Closed

Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Environmental Health Sciences Special

Emphasis Panel Community-Based

Participatory Research in Evironmental

Health (RFA 01–003).

Date: July 10–12, 2001.

Time: 7:00 p.m. to 12:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hawthorn Suites Hotel, 300

Meredity Drive, Durham, NC 27713.

Contact Person: J. Patrick Mastin, PhD.,

Scientific Review Administrator, Scientific

Review Branch/DERT, NIEHS, P.O. Box

12233 MD EC–30, Research Triangle Park,

NC 27709, (919) 541–1446.

Name of Committee: National Institute of

Environmental Health Sciences Special

Emphasis Panel RFP ES–01–08.

Date: July 20, 2001.

Time: 11:30 a.m. to 1:30 p.m.